Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_49721 | 44 | 0.92 | Mlig455_034966 | Neo: - Age: - |
CACNA2D4 | Mlig455_034966 {REF} {Length: 4816} {Pfam: VWA N-terminal [PF08399.13, score=63.0]; Neuronal voltage-dependent calcium channel alpha 2acd [PF08473.13, score=42.4]; von Willebrand factor type A domain [PF13768.8, score=29.1]; von Willebrand factor type A domain [PF00092.30, score=23.1]} {Human: ENSG00000284953, CACNA2D4, calcium voltage-gated channel auxiliary subunit alpha2delta 4, [Score=296, Expect=4e-83]; ENSG00000151062, CACNA2D4, calcium voltage-gated channel auxiliary subunit alpha2delta 4, [Score=296, Expect=4e-83]} {Mouse: ENSMUSG00000041460, Cacna2d4, calcium channel, voltage-dependent, alpha 2/delta subunit 4, [Score=302, Expect=4e-85]} {Dmel: FBgn0261041, stj, straightjacket, [Score=270, Expect=3e-74]} {Celegans: WBGene00006772, unc-36, Voltage-dependent calcium channel unc-36, [Score=191, Expect=3e-49]} {Smed: dd_Smed_v6_8926_0_2, dd_Smed_v6_8926_0_2, [Score=355, Expect=1e-103]} {RNA1509_21808, RNA1509_27675, RNA1509_48901} {RNA1310_2669.1, RNA1509_21808, RNA1509_27675, RNA1509_48901} {RNA1509_21808, RNA1509_27675, RNA1509_48901, RNA815_5027} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | -1.787 | 1.043 | 1.00000 | 1.00000 | |
RegionR2 | 0.845 | 1.043 | 0.74100 | 1.00000 | |
RegionR3 | 0.828 | 1.043 | 0.67063 | 1.00000 | |
RegionR4 | 0.027 | 1.043 | 0.80422 | 1.00000 | |
RegionR5 | -0.405 | 1.043 | 0.90492 | 1.00000 | |
RegionR6 | 1.024 | 1.043 | 0.66104 | 1.00000 | |
RegionR7 | 1.629 | 1.043 | 0.49802 | 1.00000 | |
RegionR8 | -2.161 | 1.043 | 1.00000 | 1.00000 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | -0.39 | 1.043 | 0.99983 | 1.00000 | |
RegenerationR2 | 0.881 | 1.043 | 0.78751 | 0.98557 | |
RegenerationR3 | 0.527 | 1.043 | 0.90404 | 1.00000 | |
RegenerationR4 | 1.139 | 1.043 | 0.75128 | 0.97031 | |
RegenerationR5 | -0.355 | 1.043 | 0.88459 | 1.00000 | |
RegenerationR6 | 0.547 | 1.043 | 0.80300 | 0.97860 | |
RegenerationBL | -1.755 | 1.043 | 0.99254 | 1.00000 | |
RegenerationTP | 1.56 | 1.043 | 0.61766 | 0.97099 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_49721 | 44 | 0.92 | Mlig455_034966 | Neo: - Age: - |
CACNA2D4 | 3 | 1.000 | - | - | - | 1.000 | 1.000 | Mlig455_034966 {REF} {Length: 4816} {Pfam: VWA N-terminal [PF08399.13, score=63.0]; Neuronal voltage-dependent calcium channel alpha 2acd [PF08473.13, score=42.4]; von Willebrand factor type A domain [PF13768.8, score=29.1]; von Willebrand factor type A domain [PF00092.30, score=23.1]} {Human: ENSG00000284953, CACNA2D4, calcium voltage-gated channel auxiliary subunit alpha2delta 4, [Score=296, Expect=4e-83]; ENSG00000151062, CACNA2D4, calcium voltage-gated channel auxiliary subunit alpha2delta 4, [Score=296, Expect=4e-83]} {Mouse: ENSMUSG00000041460, Cacna2d4, calcium channel, voltage-dependent, alpha 2/delta subunit 4, [Score=302, Expect=4e-85]} {Dmel: FBgn0261041, stj, straightjacket, [Score=270, Expect=3e-74]} {Celegans: WBGene00006772, unc-36, Voltage-dependent calcium channel unc-36, [Score=191, Expect=3e-49]} {Smed: dd_Smed_v6_8926_0_2, dd_Smed_v6_8926_0_2, [Score=355, Expect=1e-103]} {RNA1509_21808, RNA1509_27675, RNA1509_48901} {RNA1310_2669.1, RNA1509_21808, RNA1509_27675, RNA1509_48901} {RNA1509_21808, RNA1509_27675, RNA1509_48901, RNA815_5027} |
2. | MligTC455_07791 | 34 | 0.72 | Mlig455_056058, Mlig455_061580, Mlig455_061592, Mlig455_061982 | Neo: - Age: Up-Up-Down Region-enriched R3: 4.447/0.02029 |
ARHGAP11A | 0.97 | - | - | - | - | 0.970 | - | Mlig455_056058 {REF} {Length: 2481} {Pfam: RhoGAP domain [PF00620.29, score=67.6]} {Human: ENSG00000275568, ARHGAP11A, Rho GTPase activating protein 11A, [Score=71.6, Expect=5e-13]; ENSG00000198826, ARHGAP11A, Rho GTPase activating protein 11A, [Score=71.6, Expect=5e-13]; ENSG00000282168, ARHGAP11A, Rho GTPase activating protein 11A, [Score=70.9, Expect=6e-13]; ENSG00000285077, ARHGAP11B, Rho GTPase activating protein 11B, [Score=68.9, Expect=9e-13]; ENSG00000274734, ARHGAP11B, Rho GTPase activating protein 11B, [Score=68.9, Expect=9e-13]; ENSG00000284906, AC091057.6, Rho GTPase-activating protein 11B, [Score=68.9, Expect=9e-13]} {Mouse: ENSMUSG00000041219, Arhgap11a, Rho GTPase activating protein 11A, [Score=69.7, Expect=8e-13]} {Celegans: WBGene00015303, rga-6, Rho GTPase Activating protein, [Score=53.5, Expect=1e-07]} {RNA1310_51731} {RNA815_61027} Mlig455_061580 {REF} {Length: 1034} {Pfam: RhoGAP domain [PF00620.29, score=67.6]} {Human: ENSG00000275568, ARHGAP11A, Rho GTPase activating protein 11A, [Score=71.6, Expect=5e-13]; ENSG00000198826, ARHGAP11A, Rho GTPase activating protein 11A, [Score=71.6, Expect=5e-13]; ENSG00000282168, ARHGAP11A, Rho GTPase activating protein 11A, [Score=70.9, Expect=6e-13]; ENSG00000285077, ARHGAP11B, Rho GTPase activating protein 11B, [Score=68.9, Expect=9e-13]; ENSG00000274734, ARHGAP11B, Rho GTPase activating protein 11B, [Score=68.9, Expect=9e-13]; ENSG00000284906, AC091057.6, Rho GTPase-activating protein 11B, [Score=68.9, Expect=9e-13]} {Mouse: ENSMUSG00000041219, Arhgap11a, Rho GTPase activating protein 11A, [Score=69.7, Expect=8e-13]} {Celegans: WBGene00015303, rga-6, Rho GTPase Activating protein, [Score=53.5, Expect=1e-07]} {RNA1310_51731} Mlig455_061592 {REF} {Length: 1463} {Pfam: RhoGAP domain [PF00620.29, score=67.6]} {Human: ENSG00000275568, ARHGAP11A, Rho GTPase activating protein 11A, [Score=71.6, Expect=5e-13]; ENSG00000198826, ARHGAP11A, Rho GTPase activating protein 11A, [Score=71.6, Expect=5e-13]; ENSG00000282168, ARHGAP11A, Rho GTPase activating protein 11A, [Score=70.9, Expect=6e-13]; ENSG00000285077, ARHGAP11B, Rho GTPase activating protein 11B, [Score=68.9, Expect=9e-13]; ENSG00000274734, ARHGAP11B, Rho GTPase activating protein 11B, [Score=68.9, Expect=9e-13]; ENSG00000284906, AC091057.6, Rho GTPase-activating protein 11B, [Score=68.9, Expect=9e-13]} {Mouse: ENSMUSG00000041219, Arhgap11a, Rho GTPase activating protein 11A, [Score=69.7, Expect=8e-13]} {Celegans: WBGene00015303, rga-6, Rho GTPase Activating protein, [Score=53.5, Expect=1e-07]} {RNA1310_51731} {RNA815_11924} Mlig455_061982 {REF} {Length: 1037} {Pfam: RhoGAP domain [PF00620.29, score=68.0]} {Human: ENSG00000198826, ARHGAP11A, Rho GTPase activating protein 11A, [Score=77.4, Expect=7e-15]; ENSG00000275568, ARHGAP11A, Rho GTPase activating protein 11A, [Score=77.4, Expect=7e-15]; ENSG00000282168, ARHGAP11A, Rho GTPase activating protein 11A, [Score=76.3, Expect=1e-14]; ENSG00000285077, ARHGAP11B, Rho GTPase activating protein 11B, [Score=74.3, Expect=1e-14]; ENSG00000284906, AC091057.6, Rho GTPase-activating protein 11B, [Score=74.3, Expect=1e-14]; ENSG00000274734, ARHGAP11B, Rho GTPase activating protein 11B, [Score=74.3, Expect=1e-14]} {Mouse: ENSMUSG00000041219, Arhgap11a, Rho GTPase activating protein 11A, [Score=78.6, Expect=1e-15]} {Celegans: WBGene00015303, rga-6, Rho GTPase Activating protein, [Score=55.5, Expect=3e-08]} {RNA1310_51731} |
3. | MligTC455_16292 | 176 | 3.67 | Mlig455_029213 | Neo: Irradiation Age: Up-Down-Down, logFC(26M/2M)=-0.543 Region-enriched R2: 3.505/0.04173 |
PRKAR2B | 0.961 | - | - | - | - | 0.961 | - | Mlig455_029213 {REF} {Length: 1890} {Pfam: Cyclic nucleotide-binding domain [PF00027.31, score=75.9]} {Human: ENSG00000005249, PRKAR2B, protein kinase cAMP-dependent type II regulatory subunit beta, [Score=51.6, Expect=1e-06]; ENSG00000284096, PRKAR2B, protein kinase cAMP-dependent type II regulatory subunit beta, [Score=51.6, Expect=1e-06]} {Mouse: ENSMUSG00000002997, Prkar2b, protein kinase, cAMP dependent regulatory, type II beta, [Score=51.2, Expect=1e-06]} {Dmel: FBgn0022382, Pka-R2, Protein kinase, cAMP-dependent, regulatory subunit type 2, [Score=52.8, Expect=2e-07]} {Smed: dd_Smed_v6_14355_0_1, dd_Smed_v6_14355_0_1, [Score=104, Expect=2e-24]} {RNA1509_14151} {RNA1310_17181} {RNA815_7262} |
4. | MligTC455_16203 | 30 | 0.63 | Mlig455_025342, Mlig455_025391 | Neo: - Age: - |
VAX1 | 0.96 | - | - | - | - | 0.960 | - | Mlig455_025342 {REF} {Length: 1864} {Pfam: Homeodomain [PF00046.31, score=79.6]; Homeobox KN domain [PF05920.13, score=19.0]} {Human: ENSG00000148704, VAX1, ventral anterior homeobox 1, [RH, Score=134, Expect=2e-38]} {Mouse: ENSMUSG00000006270, Vax1, ventral anterior homeobox 1, [RH, Score=134, Expect=1e-38]} {Dmel: FBgn0008646, E5, [Score=89.7, Expect=2e-21]} {Celegans: WBGene00000430, ceh-5, Homeobox protein ceh-5, [RH, Score=94.4, Expect=2e-25]} {Smed: dd_Smed_v6_56082_0_1, dd_Smed_v6_56082_0_1, [Score=79.0, Expect=5e-19]} {RNA1310_103668} {RNA815_54191} Mlig455_025391 {REF} {Length: 2433} {Pfam: Homeodomain [PF00046.31, score=77.1]} {Human: ENSG00000148704, VAX1, ventral anterior homeobox 1, [RH, Score=135, Expect=2e-35]} {Mouse: ENSMUSG00000006270, Vax1, ventral anterior homeobox 1, [RH, Score=135, Expect=2e-35]} {Dmel: FBgn0008646, E5, [Score=90.1, Expect=6e-19]} {Celegans: WBGene00000430, ceh-5, Homeobox protein ceh-5, [Score=88.6, Expect=8e-21]} {Smed: dd_Smed_v6_56082_0_1, dd_Smed_v6_56082_0_1, [Score=79.0, Expect=5e-17]} {RNA1509_50200} {RNA1310_103668} {RNA815_54191} |
5. | MligTC455_47771 | 12 | 0.25 | Mlig455_034045, Mlig455_060426 | Neo: - Age: - |
CHRNA6, CHRNA9 | 0.96 | - | - | - | - | 0.960 | - | Mlig455_034045 {REF} {Length: 1365} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=149.2]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=60.2]} {Human: ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=206, Expect=7e-61]; ENSG00000174343, CHRNA9, cholinergic receptor nicotinic alpha 9 subunit, [Score=205, Expect=1e-60]; ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=203, Expect=3e-60]; ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=202, Expect=1e-59]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=200, Expect=1e-58]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=200, Expect=1e-58]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=200, Expect=1e-60]} {Mouse: ENSMUSG00000029205, Chrna9, cholinergic receptor, nicotinic, alpha polypeptide 9, [Score=209, Expect=1e-62]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=206, Expect=3e-61]; ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=203, Expect=4e-60]; ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=201, Expect=8e-60]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=200, Expect=5e-59]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=217, Expect=8e-65]} {Celegans: WBGene00000055, acr-16, Acetylcholine receptor subunit alpha-type acr-16, [Score=193, Expect=2e-56]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=199, Expect=2e-58]} {RNA1310_15334} {RNA815_16260.2} Mlig455_060426 {REF} {Length: 2601} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=149.4]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=46.3]} {Human: ENSG00000174343, CHRNA9, cholinergic receptor nicotinic alpha 9 subunit, [Score=200, Expect=3e-59]; ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=198, Expect=8e-59]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=195, Expect=4e-57]; ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=193, Expect=3e-56]} {Mouse: ENSMUSG00000029205, Chrna9, cholinergic receptor, nicotinic, alpha polypeptide 9, [Score=204, Expect=6e-61]; ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=197, Expect=1e-58]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=196, Expect=1e-57]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=205, Expect=1e-60]} {Celegans: WBGene00000055, acr-16, Acetylcholine receptor subunit alpha-type acr-16, [Score=183, Expect=5e-53]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=184, Expect=3e-53]} {RNA1310_15334} {RNA815_16260.2} |
6. | MligTC455_26993 | 13 | 0.28 | Mlig455_056312 | Neo: - Age: - |
ZMYM1 | 0.956 | - | - | - | - | 0.956 | - | Mlig455_056312 {REF} {Length: 2369} {Pfam: hAT family C-terminal dimerisation region [PF05699.16, score=50.8]} {Human: ENSG00000197056, ZMYM1, zinc finger MYM-type containing 1, [Score=50.1, Expect=6e-07]} {Mouse: ENSMUSG00000043872, Zmym1, zinc finger, MYM domain containing 1, [Score=49.7, Expect=5e-07]} {Smed: dd_Smed_v6_13305_1_1, dd_Smed_v6_13305_1_1, [Score=79.7, Expect=6e-18]} {RNA1509_17407} {RNA1310_2113} {RNA815_4403} |
7. | MligTC455_03734 | 28 | 0.58 | Mlig455_006090 | Neo: - Age: - |
0.953 | - | - | - | - | 0.953 | - | Mlig455_006090 {REF} {Length: 1406} {Pfam: Methyltransferase domain [PF13383.8, score=64.8]; Methyltransferase FkbM domain [PF05050.14, score=39.6]} {Smed: dd_Smed_v6_3811_0_2, dd_Smed_v6_3811_0_2, [Score=172, Expect=8e-51]} {RNA1310_105941} | |
8. | MligTC455_06426 | 14 | 0.3 | Mlig455_045703 | Neo: - Age: - |
0.953 | - | - | - | - | 0.953 | - | Mlig455_045703 {REF} {Length: 756} {NoTransDecoderORF} {RNA1310_88574} {RNA815_52979} | |
9. | MligTC455_07894 | 82 | 1.71 | Mlig455_069229 | Neo: - Age: - |
0.953 | - | - | - | - | 0.953 | - | Mlig455_069229 {REF} {Length: 281} {NoTransDecoderORF} {RNA1509_11387} {RNA1310_98146} {RNA815_3258.3} | |
10. | MligTC455_08618 | 16 | 0.33 | Mlig455_067561 | Neo: - Age: - |
0.953 | - | - | - | - | 0.953 | - | Mlig455_067561 {REF} {Length: 675} {Pfam: Integrase zinc binding domain [PF17921.3, score=45.4]; H2C2 zinc finger [PF09337.12, score=18.8]} {Smed: dd_Smed_v6_18260_0_1, dd_Smed_v6_18260_0_1, [RH, Score=42.7, Expect=9e-06]} | |
11. | MligTC455_05557 | 49 | 1.02 | Mlig455_054327 | Neo: - Age: - Region-enriched R4: 4.473/0.00273 |
0.951 | - | - | - | - | 0.951 | - | Mlig455_054327 {REF} {Length: 519} {NoTransDecoderORF} {RNA1509_38197} {RNA1310_90831} {RNA815_43533} | |
12. | MligTC455_17602 | 62 | 1.3 | Mlig455_065788 | Neo: - Age: - |
0.951 | - | - | - | - | 0.951 | - | Mlig455_065788 {REF} {Length: 1038} {NoTransDecoderORF} {RNA1509_9817} {RNA1310_14959.1} {RNA815_22311} | |
13. | MligTC455_30252 | 320 | 6.67 | Mlig455_014555, Mlig455_014804, Mlig455_020511, Mlig455_070712 | Neo: - Age: - Regeneration-upregulated R4: 3.499 Regeneration-enriched R4: 3.499 |
0.951 | - | - | - | - | 0.951 | - | Mlig455_014555 {REF} {Length: 382} {NoTransDecoderORF} {RNA1509_33210} {RNA1310_3607.1} {RNA815_31436} Mlig455_014804 {REF} {Length: 512} {RNA1509_33210} {RNA1310_3607.1} {RNA815_31436} Mlig455_020511 {REF} {Length: 1291} {RNA1509_33034} {RNA1310_58613} {RNA815_41212} Mlig455_070712 {REF} {Length: 653} {RNA1310_58613} {RNA815_41212} |
|
14. | MligTC455_09107 | 11 | 0.24 | Mlig455_059945 | Neo: - Age: - |
0.95 | - | - | - | - | 0.950 | - | Mlig455_059945 {REF} {Length: 465} {NoTransDecoderORF} {RNA1509_58333} {RNA1310_141885} {RNA815_39121} | |
15. | MligTC455_16293 | 241 | 5.01 | Mlig455_029235 | Neo: Irradiation Age: Up-Down-Down |
0.95 | - | - | - | - | 0.950 | - | Mlig455_029235 {REF} {Length: 1804} {Pfam: Cyclic nucleotide-binding domain [PF00027.31, score=61.3]} {Smed: dd_Smed_v6_14355_0_1, dd_Smed_v6_14355_0_1, [Score=81.3, Expect=8e-17]} {RNA1509_14151} {RNA1310_17181} {RNA815_7262} | |
16. | MligTC455_38650 | 189 | 3.94 | Mlig455_026837 | Neo: - Age: Up-Down-Down, logFC(26M/2M)=-0.460 Region-enriched R4: 2.120/0.00387 |
0.95 | - | - | - | - | 0.950 | - | Mlig455_026837 {REF} {Length: 2348} {Dmel: FBgn0011705, rost, rolling stone, [RH, Score=70.5, Expect=1e-13]} {RNA1509_29979} {RNA1310_35196} {RNA815_13054.1} |